ARA-290 12 mg – Product Description
ARA-290 12 mg is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to deliver tissue-protective and anti-inflammatory benefits without affecting red blood cell production. It is designed to target the innate repair receptor (IRR), helping the body respond to injury, inflammation, and cellular stress.
ARA-290 has been studied for its potential role in supporting nerve repair, reducing chronic inflammation, and improving symptoms associated with conditions such as neuropathy and metabolic dysfunction. Its mechanism focuses on promoting healing at the cellular level while minimizing the risks typically associated with traditional EPO therapies.
The 12 mg formulation is typically administered via subcutaneous injection, often in cycles depending on the treatment protocol and clinical guidance.
Key Benefits:
- Supports nerve repair and regeneration
- Helps reduce inflammation and cellular stress
- Does not stimulate red blood cell production
- Potential benefits for neuropathic and metabolic conditions
Administration:
Administered by subcutaneous injection as directed by a qualified healthcare provider.
Common Side Effects:
Generally well tolerated; mild injection site reactions or temporary discomfort may occur in some individuals.
Important Note:
ARA-290 is considered an investigational peptide and may not be approved for general medical use in many regions. Its use should be guided strictly by a healthcare professional or within clinical research settings.
Reviews
There are no reviews yet.